Lotsch F, Vingerling R, Spijker R, Grobusch MP, 2017. Toxocariasis in humans in Africa—a systematic review. Travel Med Infect Dis 20: 15–25.
Starr MC, Montgomery SP, 2011. Soil-transmitted helminthiasis in the United States: a systematic review—1940–2010. Am J Trop Med Hyg 85: 680–684.
Despommier D, 2003. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 16: 265–272.
Woodhall DM, Eberhard ML, Parise ME, 2014. Neglected parasitic infections in the United States: toxocariasis. Am J Trop Med Hyg 90: 810–813.
Stewart JM, Cubillan LD, Cunningham ET Jr., 2005. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 25: 1005–1013.
Schantz PM, Meyer D, Glickman LT, 1979. Clinical, serologic, and epidemiologic characteristics of ocular toxocariasis. Am J Trop Med Hyg 28: 24–28.
Liu EW, Chastain HM, Shin SH, Wiegand RE, Kruszon-Moran D, Handali S, Jones JL, 2018. Seroprevalence of antibodies to Toxocara species in the United States and associated risk factors, 2011–2014. Clin Infect Dis 66: 206–212.
Semega JL, Fontenot KR, Kollar MA, 2017. Income and Poverty in the United States: 2016. The United States Census Bureau. Available at: https://www.census.gov/data/tables/2017/demo/income-poverty/p60-259.html. Accessed February 14, 2018.
Bailey JH, Beacham T, Weeks K, Smith CC, Horn M, Herrin V, 2010. Can the delta stop singing the blues? J Miss State Med Assoc 51: 242–246.
Ma G, Holland CV, Wang T, Hofmann A, Fan CK, Maizels RM, Hotez PJ, Gasser RB, 2018. Human toxocariasis. Lancet Infect Dis 18: e14–e24.
Shields JA, 1984. Ocular toxocariasis. A review. Surv Ophthalmol 28: 361–381.
Centers for Disease Control and Prevention, 2011. Ocular toxocariasis—United States, 2009–2010. MMWR Morb Mortal Wkly Rep 60: 734–736.
Ahn SJ et al. 2014. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis 8: e2938.
Ávila M, Isaac D, 2018. Helminthic Disease. Ryan’s Retina, 6th edition. Amsterdam, The Netherlands: Elsevier Inc., 1685–1699.
Felberg NT, Shields JA, Federman JL, 1981. Antibody to Toxocara canis in the aqueous humor. Arch Ophthalmol 99: 1563–1564.
Woodhall DM, Fiore AE, 2014. Toxocariasis: a review for pediatricians. J Pediatric Infect Dis Soc 3: 154–159.
Woodhall DM, Garcia AP, Shapiro CA, Wray SL, Shane AL, Mani CS, Stimpert KK, Fox LM, Montgomery SP, 2017. Assessment of U.S. pediatrician knowledge of toxocariasis. Am J Trop Med Hyg 97: 1243–1246.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||1452||386||4|
Ocular toxocariasis can be vision threatening, and is commonly reported from tropical or subtropical regions. Knowledge of clinical manifestations from the United States, particularly in underserved areas such as the American South, is lacking. We report three cases of ocular toxocariasis in individuals from the Mississippi Delta, a rural community with prevalent poverty. Visual acuity was severely affected in two of the three cases. Increased awareness of ocular toxocariasis, which may have under-recognized frequency, will contribute to prompt diagnosis and treatment, which will ultimately improve patient health in the region.
Disclaimer: The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry.
Disclosure: R. S. B. has a patent (PCT/US2018/052469: Removing Interfering Host Nucleic Acids for Molecular Parasite Detection) issued to Centers for Disease Control and Prevention.
Authors’ addresses: Kengo Inagaki and Irene Arguello, Division of Infectious Disease, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS, E-mails: firstname.lastname@example.org and email@example.com. Brian Kirmse, Division of Genetics, Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS, E-mail: firstname.lastname@example.org. Richard S. Bradbury, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, and School of Health, Medical and Applied Sciences, Central Queensland University, Rockhampton, Australia, E-mail: email@example.com. Ramana S. Moorthy, Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, E-mail: firstname.lastname@example.org. Charles D. McGuffey, Department of Transitional Medicine, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, TN, E-mail: email@example.com. Brian Tieu, Department of Ophthalmology, University of Mississippi Medical Center, Jackson, MS, E-mail: firstname.lastname@example.org. Charlotte V. Hobbs, Division of Infectious Disease, Department of Pediatrics and Department of Microbiology, Batson Children’s Hospital, University of Mississippi Medical Center, Jackson, MS, E-mail: email@example.com.
These authors contributed equally to this work.